Wheeze and Intermittent Treatment

NCT01142505 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1358

Enrollment

OTHER

Sponsor class

Conditions

Wheezing

Interventions

DRUG: Mannitol
DRUG: Montelukast

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]